as on March 6, 2026 at 7:59 am IST
Day's Low
Day's High
0.64%
Downside
0.76%
Upside
52 Week's Low
52 Week's High
0.85%
Downside
33.59%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$112.2B
EPS (TTM)
5.0079
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
0.02%
PE Ratio (TTM)
19.61
Industry PE ratio
17.692948717948717
PEG Ratio
0.7202
EBITDA
12.6B
Revenue (TTM)
46.7B
Profit Margin
16.72%
Return On Equity TTM
6.66%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Industry (17.69x)
March 5, 2026
Today (19.61x)
March 5, 2026
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 19.61x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $112.2B | -0.79% | 19.61 | 16.72% | |
| BUY | $901.9B | 385% | 44.45 | 31.67% | |
| BUY | $312.8B | 319.33% | 30.85 | 17.41% | |
| BUY | $594.6B | 57.14% | 22.37 | 28.46% | |
| BUY | $413.5B | 121.36% | 99.09 | 6.91% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹81,450
Returns
Returns from Sanofi Stock
Dollar Returns*
₹5,372 (+5.37%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $57.68
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
21.98%UPSIDE
Target Price
$57.68
Current Price
$45
Analyzed by
31 Analysts
Target
$57.68
Sanofi target price $57.68, a slight upside of 21.98% compared to current price of $45. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has grown by 81.57% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:81.57% versus previous 30 day period
Search interest for Sanofi Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 March
Tue, 08:30 PM
-Sanofi receives orphan drug designation for Waylirz in Japan for IgG4-related disease treatment.
Tue, 09:20 PM
-Regeneron and Sanofi receive positive EMA opinion for Dupixent's expanded use in children with CSU.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, ASTRAZENECA PLC has given 158.5% return, outperforming this stock by 180.4%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 209.1% return, outperforming this stock by 212.3%
Revenue Fall
![]()
Sanofi's revenue has been declining for the past two quarters. It decreased from $13.17 billion to $12.20 billion, averaging a decline of 7.3% each quarter.
Profit Down
![]()
Sanofi's net profit has been declining for the last three quarters. It decreased from $3.94 billion to -$801 million, showing an average decrease of 78.7% each quarter.
Price Dip
![]()
In the last 7 days, SNY stock has moved down by -4.4%
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande ArmEe, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Olivier Charmeil |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. François-Xavier Roger | Executive VP & CFO |
Mr. Thomas Kudsk Larsen | Head of Investor Relations & General Medicines |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. Olivier Charmeil | Interim CEO & Executive VP of General Medicines |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Mr. Erik Wallström | Head of Therapeutic Area - Neurology Development |
Mr. Thomas Triomphe | Executive Vice President of Vaccines |
Sanofi share price today is $45 as on at the close of the market. Sanofi share today touched a day high of $45.34 and a low of $44.71.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.62 on . Sanofi stock price today i.e. is closed at $45,which is 25.14% down from its 52 week high and 0.86% up from its 52 week low.
Sanofi market capitalisation is $0.11T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹91.558 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.58 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $45 as on March 6, 2026 at 2:29 am IST, you will get 0.2222 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -0.79% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?